Valuation (24%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -1.27 | N/A |
| PEG Ratio (TTM) | -0.17 | N/A |
| P/S Ratio (TTM) | 0.73 | N/A |
| P/B Ratio (TTM) | 3.06 | N/A |
| P/FCF Ratio (TTM) | 26.75 | N/A |
| Price to 5YR AVG Earnings Ratio | -8.62 | N/A |
| Price to 5YR AVG FCF Ratio | -17.71 | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -40.50% | N/A |
| ROE (TTM) | -159.40% | N/A |
| Net Profit Margin (TTM) | -56.95% | N/A |
| ROIC 5YR AVG | -9.30% | N/A |
Growth (18%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -30.90% | -180.59% | -571.05% |
| Revenue | -4.06% | 2.29% | 20.21% |
| Net Income | -31.09% | -179.34% | -690.55% |
| Cash Flow | 13.31% | -13,389.89% | -8,344.41% |
Health (35%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.10 | N/A |
| Quick Ratio (TTM) | 1.17 | N/A |
| D/E Ratio (TTM) | 0.12 | N/A |
| Interest Coverage (TTM) | -4.49 | N/A |
| Piotroski F-Score | 3 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | -6.09 | N/A |
| Shares Outstanding Growth 5YR AVG | 11.11% | N/A |